Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Suspended × CNS × Clear all

Phase

Phase NA 14 Phase 1 8 Phase 2 6 Phase 1/2 5 Phase 3 1

Status

Completed 135 Unknown 45 Recruiting 42 Terminated 25 Active not recruiting 21 Not yet recruiting 12 Withdrawn 8 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 7 Thoracic 5 Gastrointestinal 4 Other hematologic neoplasm 3 Lymphoid 3 Gynecologic 2 Genitourinary 2 Classical hematology 2 Tumor-Agnostic 1 Plasma cell 1 Other 1 Myeloid 1 CNS 1

Conditions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02546102 2024-04-03

Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma

Precision Life Sciences Group

Phase 3 Suspended

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡